Electra Therapeutics

Electra Therapeutics is a clinical-stage biotechnology company that specializes in the treatment of cancer and other immunological diseases. It develops therapies that target signal regulatory proteins (SIRP). The company provides ELA026, a monoclonal antibody designed to address severe inflammatory disorders with aberrant myeloid and T cell activity.